These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. Rothlind JC; York MK; Carlson K; Luo P; Marks WJ; Weaver FM; Stern M; Follett K; Reda D; J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):622-9. PubMed ID: 25185211 [TBL] [Abstract][Full Text] [Related]
11. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease. Smeding HM; Speelman JD; Huizenga HM; Schuurman PR; Schmand B J Neurol Neurosurg Psychiatry; 2011 Jul; 82(7):754-60. PubMed ID: 19465417 [TBL] [Abstract][Full Text] [Related]
12. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease. Higuchi MA; Tsuboi Y; Inoue T; Fukuyama K; Abe H; Baba Y; Yamada T Neuromodulation; 2015 Feb; 18(2):113-7. PubMed ID: 24799286 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947 [TBL] [Abstract][Full Text] [Related]
14. The impact of subthalamic deep brain stimulation on caregivers of Parkinson's disease patients: an exploratory study. Lewis CJ; Maier F; Horstkötter N; Eggers C; Visser-Vandewalle V; Moro E; Zurowski M; Kuhn J; Woopen C; Timmermann L J Neurol; 2015 Feb; 262(2):337-45. PubMed ID: 25381461 [TBL] [Abstract][Full Text] [Related]
15. Tackling psychosocial maladjustment in Parkinson's disease patients following subthalamic deep-brain stimulation: A randomised clinical trial. Flores Alves Dos Santos J; Tezenas du Montcel S; Gargiulo M; Behar C; Montel S; Hergueta T; Navarro S; Belaid H; Cloitre P; Karachi C; Mallet L; Welter ML PLoS One; 2017; 12(4):e0174512. PubMed ID: 28399152 [TBL] [Abstract][Full Text] [Related]
16. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients. Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620 [TBL] [Abstract][Full Text] [Related]
17. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease. Martinez-Fernandez R; Pelissier P; Quesada JL; Klinger H; Lhommée E; Schmitt E; Fraix V; Chabardes S; Mertens P; Castrioto A; Kistner A; Broussolle E; Pollak P; Thobois S; Krack P J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):311-8. PubMed ID: 25934016 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease. Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564 [TBL] [Abstract][Full Text] [Related]
19. Effects of subthalamic nucleus stimulation and levodopa on decision-making in Parkinson's disease. Atkinson-Clement C; Cavazzini É; Zénon A; Witjas T; Fluchère F; Azulay JP; Baunez C; Eusebio A Mov Disord; 2019 Mar; 34(3):377-385. PubMed ID: 30681186 [TBL] [Abstract][Full Text] [Related]
20. Effects of bilateral stimulation of the subthalamic nucleus in Parkinson's disease with and without REM sleep behaviour disorder. Bargiotas P; Debove I; Bargiotas I; Lachenmayer ML; Ntafouli M; Vayatis N; Schüpbach MW; Krack P; Bassetti CL J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1310-1316. PubMed ID: 31422368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]